Abstract

Intraoperative blood salvage reduces the requirements for allogenic blood transfusion and transfusion related inflammatory response in abdominal aortic aneurysm surgery: Blood transfusion and abdominal aortic aneurysm surgery

Highlights

  • Intraoperative blood salvage (IBS) is a procedure involving recovering blood looses during surgery and reinfusing it into the patient with a purpose to reduce the perioperative morbidity and mortality associated with complications after administration of allogenic transfusion (AT)

  • The aim of this study was to investigate whether the IBS reduces the need for allogenic transfusion requirements and for non-invasive ventilation (NIV) and/or oxygen supplementation and whether it was associated with decreased levels of inflammatory markers following abdominal aortic aneurysm (AAA) surgery

  • The postoperatively average white blood cell count (WBCC) was significantly higher among patients in NCS group compared to those from CS group (12.89 x 109 vs. 10.44 x109; p=0.014)

Read more

Summary

Summary

Uvod: Intraoperativno spašavanje krvi je procedura koja zahteva upotrebu posebnih aparata za prikupljanje i obradu izgubljene krvi tokom hirurških intervencija i vraćanja iste nazad u cirkulacioni sistem bolesnika, a sa ciljem redukcije postoperativnog morbiditeta i mortaliteta, povezanih sa komplikacijama nakon primene alogenih transfuzija. Cilj ove studije bio je ispitivanje efikasnosti intraoperativnog spašavanja krvi kroz smanjenje potrebe za alogenim transfuzijama, učestalosti upotrebe neinvazivne (NIV) ventilacije i/ili kiseonične suplementacije i nivoa vrednosti markera zapaljenja nakon operacija aneurizme abdominalne aorte. Perioperativno spašavanje krvi pomoću „Haemonetics cell saver 5+” korišćeno je kod 24/51 (47,05 %) pacijenata (CS grupa), dok 27/51 (52,95%) nije dobijalo autotransfuziju (NCS grupa). Praćene su vrednosti markera zapaljenja (broj leukocita, C-reaktivni protein (CRP), prokalcitonin (PCT) i fibrinogen), potreba za neinvazivnom ventilacijom (NIV) i kiseoničnom suplementacijom, kao i količina upotrebljene alogene transfuzije. Rezultati: Rezultati pokazuju da je potreba za intra i postoperativnim alogenim transfuzijama krvi bila značajno veća kod bolesnika iz NCS grupe u poređenju sa onima iz CS grupe (3,63 ± 1,07 naspram 0,58 ± 0,83 jedinica po pacijentu; p < 0,001). Neinvazivna respiratorna potpora je češće korišćena u NCS grupi (4/27) u poređenju sa CS grupom (1/24), ali ova razlika nije bila

Introduction
Findings
National Blood Resource Education Program
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.